A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer.
Journal: Future Oncology (London, England)
Published:
Abstract
[Figure: see text].
Authors
Kim Chi, Dana Rathkopf, Matthew Smith, Eleni Efstathiou, Gerhardt Attard, David Olmos, Ji Lee, Eric Small, Andrea Pereira De Santana Gomes, Guilhem Roubaud, Marniza Saad, Bogdan Zurawski, Valerii Sakalo, Gary Mason, Peter Francis, George Wang, Daphne Wu, Brooke Diorio, Angela Lopez Gitlitz, Shahneen Sandhu
Relevant Conditions